$Johnson & Johnson (JNJ.US)$ is a global healthcare company with a broad portfolio of consumer, pharmaceutical, and medical device products.
There is plenty of events ongoing apart from the results.
So here is what investors need to take note of.
1. Overall Q2'23 results are good
Overall results have been good for Q2'23.
Sales are up 6.3% while EPS is up by 8.1%.
Most regions reported steady growth, just apart from Europe where sales shrunk a bit.
2. Kenvue spin-...

$Meta Platforms (META.US)$ is finally turning back into a meta stock!
Not metaverse, but the "meta" used in gaming - a stock that you cannot disregard and ignore in terms of portfolio construction.
After the nightmares of Cambridge Analytica and the heavy pressure from TikTok, Meta is shining once again.
Here are some key info that investors might need to take note of.
1. Facebook is for old gen people - no problem!
Facebook might not be the go-to app for a lot o...

It seems like $Intel (INTC.US)$ is back from the dead!
After two straight quarters of losses, Intel is finally back in the black.
Not only that, it has issued a stronger forecast.
The share price jumped after the results
So is it time to enter into this chip IDM?
1. Down YoY, but beat estimates, so share price is up
YoY-wise, everything is down for Intel.
Under normal circumstances, share prices should be reacting negatively.
However, the gloomy forecasts provided a few...

$ASML Holding (ASML.US)$ stock is doing well these days
In light of better results, stock prices have shown up trend.
But what are the key points and potential pitfalls if any?
1. Revenue and gross profit is up
Previously a concern highlighting sales disruption due to restrictions on certain regulations might affect sales growth.
This might have no effect or little effect on the current Q2'23 results.
Revenue is up 2.31% from the preceding quarter, while the gross margin is...